The Valley Desk

ArticleCancerPublished

Optimizing safety and efficacy of asparaginase and blinatumomab therapy in frontline acute lymphoblastic leukemia regimens in diverse health care settings-international expert consensus

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Children’s Hospital of Philadelphia. Affiliation source

Publication record

Type
Article
Venue
Cancer
Published
Subject terms
Humans; Drug Hypersensitivity; Asparaginase; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Bispecific; Drug Monitoring; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Acute lymphoblastic leukemia; therapeutic drug monitoring; Blinatumomab
PubMed ID
42578884
PubMed Central ID
PMC13459976
Added to directory
Source checked

Report a correction or request removal